Literature DB >> 26070409

Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease.

Mariana Verdelho Machado1, Gregory Alexander Michelotti2, Thiago Almeida Pereira2, Guanhua Xie2, Richard Premont2, Helena Cortez-Pinto3, Anna Mae Diehl4.   

Abstract

BACKGROUND & AIMS: Mechanisms that regulate regeneration of injured livers are complex. YAP, a stem cell associated factor, controls liver growth in healthy adult mice. Increasing nuclear localization of YAP triggers accumulation of reactive-appearing ductular cells (YAP+RDC) with liver progenitor capabilities. The significance of YAP activation, and mechanisms involved, are unknown in diseased livers. We evaluated the hypothesis that YAP is more activated in injured livers that are scarring than in those that are regenerating effectively.
METHODS: Immunohistochemistry and qRT-PCR analysis were used to localize and quantify changes in YAP and RDC in 52 patients with non-alcoholic fatty liver disease (NAFLD) and two mouse models of diet-induced non-alcoholic steatohepatitis (NASH). Results were correlated with liver disease severity, metabolic risk factors, and factors proven to control NAFLD progression.
RESULTS: YAP increased in NAFLD where it mainly localized in nuclei of RDC that expressed progenitor markers. Accumulation of YAP+RDC paralleled the severity of hepatocyte injury and accumulation of Sonic hedgehog, but not steatosis or metabolic risk factors. YAP+RDC expressed osteopontin, a Shh-regulated fibrogenic factor. Myofibroblast accumulation, fibrosis, and numbers of YAP+RDC strongly correlated. In murine NASH models, atrophic fibrotic livers contained significantly more YAP+RDC than livers with less severe NASH.
CONCLUSION: YAP+RDC promote scarring, rather than effective regeneration, during NASH.
Copyright © 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ductular reaction; Fibrosis; Non-alcoholic steatohepatitis; Regeneration; YAP

Mesh:

Substances:

Year:  2015        PMID: 26070409      PMCID: PMC4575842          DOI: 10.1016/j.jhep.2015.05.031

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  39 in total

1.  Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease.

Authors:  Cynthia D Guy; Ayako Suzuki; Marzena Zdanowicz; Manal F Abdelmalek; James Burchette; Aynur Unalp; Anna Mae Diehl
Journal:  Hepatology       Date:  2012-04-18       Impact factor: 17.425

2.  Hippo pathway activity influences liver cell fate.

Authors:  Dean Yimlamai; Constantina Christodoulou; Giorgio G Galli; Kilangsungla Yanger; Brian Pepe-Mooney; Basanta Gurung; Kriti Shrestha; Patrick Cahan; Ben Z Stanger; Fernando D Camargo
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

3.  Evidence for and against epithelial-to-mesenchymal transition in the liver.

Authors:  Guanhua Xie; Anna Mae Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-24       Impact factor: 4.052

4.  YAP regulates neuronal differentiation through Sonic hedgehog signaling pathway.

Authors:  Yi-Ting Lin; Jing-Ya Ding; Ming-Yang Li; Tien-Shun Yeh; Tsu-Wei Wang; Jenn-Yah Yu
Journal:  Exp Cell Res       Date:  2012-05-30       Impact factor: 3.905

5.  YAP1 increases organ size and expands undifferentiated progenitor cells.

Authors:  Fernando D Camargo; Sumita Gokhale; Jonathan B Johnnidis; Dongdong Fu; George W Bell; Rudolf Jaenisch; Thijn R Brummelkamp
Journal:  Curr Biol       Date:  2007-11-01       Impact factor: 10.834

6.  Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis.

Authors:  Steve S Choi; Alessia Omenetti; Rafal P Witek; Cynthia A Moylan; Wing-Kin Syn; Youngmi Jung; Liu Yang; Debra L Sudan; Jason K Sicklick; Gregory A Michelotti; Marcos Rojkind; Anna Mae Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-10-08       Impact factor: 4.052

7.  Smoothened is a master regulator of adult liver repair.

Authors:  Gregory A Michelotti; Guanhua Xie; Marzena Swiderska; Steve S Choi; Gamze Karaca; Leandi Krüger; Richard Premont; Liu Yang; Wing-Kin Syn; Daniel Metzger; Anna Mae Diehl
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

8.  Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.

Authors:  Wing-Kin Syn; Steve S Choi; Evaggelia Liaskou; Gamze F Karaca; Kolade M Agboola; Ye Htun Oo; Zhiyong Mi; Thiago A Pereira; Marzena Zdanowicz; Padmini Malladi; Yuping Chen; Cynthia Moylan; Youngmi Jung; Syamal D Bhattacharya; Vanessa Teaberry; Alessia Omenetti; Manal F Abdelmalek; Cynthia D Guy; David H Adams; Paul C Kuo; Gregory A Michelotti; Peter F Whitington; Anna Mae Diehl
Journal:  Hepatology       Date:  2010-10-21       Impact factor: 17.425

9.  Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease.

Authors:  Mariana Verdelho Machado; Gregory Alexander Michelotti; Guanhua Xie; Thiago Almeida Pereira; Thiago Pereira de Almeida; Jerome Boursier; Brittany Bohnic; Cynthia D Guy; Anna Mae Diehl
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

10.  Osteopontin deletion prevents the development of obesity and hepatic steatosis via impaired adipose tissue matrix remodeling and reduced inflammation and fibrosis in adipose tissue and liver in mice.

Authors:  Andoni Lancha; Amaia Rodríguez; Victoria Catalán; Sara Becerril; Neira Sáinz; Beatriz Ramírez; María A Burrell; Javier Salvador; Gema Frühbeck; Javier Gómez-Ambrosi
Journal:  PLoS One       Date:  2014-05-28       Impact factor: 3.240

View more
  46 in total

Review 1.  Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine.

Authors:  Anwesha Dey; Xaralabos Varelas; Kun-Liang Guan
Journal:  Nat Rev Drug Discov       Date:  2020-06-17       Impact factor: 84.694

2.  Oroxylin A inhibits ethanol-induced hepatocyte senescence via YAP pathway.

Authors:  Huanhuan Jin; Naqi Lian; Mianli Bian; Chenxi Zhang; Xingran Chen; Jiangjuan Shao; Li Wu; Anping Chen; Qinglong Guo; Feng Zhang; Shizhong Zheng
Journal:  Cell Prolif       Date:  2018-01-10       Impact factor: 6.831

3.  Yes-Associated Protein in Kupffer Cells Enhances the Production of Proinflammatory Cytokines and Promotes the Development of Nonalcoholic Steatohepatitis.

Authors:  Kyoungsub Song; Hyunjoo Kwon; Chang Han; Weina Chen; Jinqiang Zhang; Wenbo Ma; Srikanta Dash; Chandrashekhar R Gandhi; Tong Wu
Journal:  Hepatology       Date:  2020-04-11       Impact factor: 17.425

Review 4.  Emerging concepts in biliary repair and fibrosis.

Authors:  Luca Fabris; Carlo Spirli; Massimiliano Cadamuro; Romina Fiorotto; Mario Strazzabosco
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-19       Impact factor: 4.052

5.  Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis.

Authors:  Xiaobo Wang; Ze Zheng; Jorge Matias Caviglia; Kathleen E Corey; Tina M Herfel; Bishuang Cai; Ricard Masia; Raymond T Chung; Jay H Lefkowitch; Robert F Schwabe; Ira Tabas
Journal:  Cell Metab       Date:  2016-10-27       Impact factor: 27.287

Review 6.  Pathogenesis of Nonalcoholic Steatohepatitis.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2016-02-27       Impact factor: 22.682

7.  AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes.

Authors:  Ali Dehnad; Weiguo Fan; Joy X Jiang; Sarah R Fish; Yuan Li; Suvarthi Das; Gergely Mozes; Kimberly A Wong; Kristin A Olson; Gregory W Charville; Mohammed Ali; Natalie J Török
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

Review 8.  Mechanisms of hepatic stellate cell activation.

Authors:  Takuma Tsuchida; Scott L Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-10       Impact factor: 46.802

Review 9.  The hedgehog pathway in nonalcoholic fatty liver disease.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-03-20       Impact factor: 8.250

10.  Enhanced Steatosis and Fibrosis in Liver of Adult Offspring Exposed to Maternal High-Fat Diet.

Authors:  Michael D Thompson; Mary J Cismowski; Aaron J Trask; Scott W Lallier; Amanda E Graf; Lynette K Rogers; Pamela A Lucchesi; David R Brigstock
Journal:  Gene Expr       Date:  2016-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.